Opioid Use Disorder - Epidemiology Forecast to 2028

2020-07-30
Price :
Published : Jul-2020
No. of Pages : 34
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Opioid Use Disorder: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources Used
3.4.2 Forecast Assumptions and Methods
3.4.3 Forecast Assumptions and Methods: 12-Month Total Prevalent Cases of OUD
3.4.4 Forecast Assumptions and Methods: 12-Month Diagnosed Prevalent Cases of OUD
3.4.5 Forecast Assumptions and Methods: 12-Month Total and Diagnosed Prevalent Cases of OUD by Severity
3.4.6 Sources Not Used
3.5 Epidemiological Forecast for OUD (2018-2028)
3.5.1 12-Month Total Prevalent Cases of OUD
3.5.2 Age-Specific 12-month Total Prevalent Cases of OUD
3.5.3 Sex-Specific 12-Month Total Prevalent Cases of OUD
3.5.4 12-Month Total Prevalent Cases of OUD by Severity
3.5.5 12-Month Diagnosed Prevalent Cases of OUD
3.5.6 Age-Specific 12-Month Diagnosed Prevalent Cases of OUD
3.5.7 Sex-Specific 12-Month Diagnosed Prevalent Cases of OUD
3.5.8 12-month Diagnosed Prevalent Cases of OUD by Severity
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of Analysis
3.6.3 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer

List of Tables
Table 1: Summary of Newly Added Data Types
Table 2: Summary of Updated Data Types
Table 3: Risk Factors and Comorbidities for OUD

List of Figures
Figure 1: 8MM, 12-Month Total Prevalent Cases of OUD, Both Sexes, N, Ages ?18 Years, 2018 and 2028
Figure 2: 8MM, 12-Month Diagnosed Prevalent Cases of OUD, Both Sexes, N, Ages ?18 Years, 2018 and 2028
Figure 3: 8MM, 12-Month Total Prevalence of OUD, Men and Women, %, Ages ?18 Years, 2018
Figure 4: 8MM, 12-Month Diagnosed Prevalence of OUD, Men and Women, %, Ages ?18 Years, 2018
Figure 5: 8MM, Sources Used and Not Used to Forecast the 12-Month Total and 12-Month Diagnosed Prevalent Cases of OUD
Figure 6: 8MM, Sources Used to Forecast the Severity of 12-Month Total Prevalent Cases of OUD
Figure 7: 8MM, Sources Used to Forecast the Severity of 12-Month Diagnosed Prevalent Cases of OUD
Figure 8: 8MM, 12-Month Total Prevalent Cases of OUD, Both Sexes, Ages ?18 Years, N, 2018
Figure 9: 8MM, 12-Month Total Prevalent Cases of OUD by Age, N, Both Sexes, 2018
Figure 10: 8MM, 12-Month Total Prevalent Cases of OUD by Sex, N, Ages ?18 Years, 2018
Figure 11: 8MM 12-Month Total Prevalent Cases of OUD by Severity, N, Ages ?18 Years, 2018
Figure 12: 8MM, 12-Month Diagnosed Prevalent Cases of OUD, N, Both Sexes, Ages ?18 Years, 2018
Figure 13: 8MM, 12-Month Diagnosed Prevalent Cases of OUD by Age, N, Both Sexes, 2018
Figure 14: 8MM, 12-Month Diagnosed Prevalent Cases of OUD by Sex, N, Ages ?18 Years, 2018
Figure 15: 8MM, 12-Month Diagnosed Prevalent Cases of OUD by Severity, N, Ages ?18 Years, 2018
Filed in: Pharmaceutical
Publisher : GlobalData